Endovia Health Sciences, Inc. (EDVA)
ASE · Healthcare · Biotechnology
$0.15
-2.42%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.7M
Shares Outstanding
11.1M
P/S (TTM)
-4.6x
Exchange
ASE
Currency
USD
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | (365K) | 4K | 0.00 |
| Gross Profit | 0.00 | 47K | 2K | 0.00 |
| Operating Income | (9.5M) | (976K) | (979K) | (2.0M) |
| Net Income | (9.9M) | (3.2M) | (2.1M) | (2.1M) |
| Diluted EPS | $-18.04 | N/A | $-1.88 | $-0.79 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 18.1M | 18.9M | 801K | 73K |
| Gross Profit | 5.9M | 5.6M | (120K) | 17K |
| Operating Income | (21.4M) | (15.3M) | (9.9M) | (14.2M) |
| Net Income | (21.7M) | (21.0M) | (23.8M) | (25.2M) |
| Diluted EPS | $-92.80 | $-79.16 | $-70.72 | $-47.88 |